HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.830
+0.370 (10.69%)
At close: Dec 20, 2024, 4:00 PM
3.520
-0.310 (-8.09%)
After-hours: Dec 20, 2024, 7:53 PM EST
HeartSciences Employees
HeartSciences had 15 employees as of April 30, 2024. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
$980
Profits / Employee
-$508,305
Market Cap
3.75M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 15 | 3 | 25.00% |
| Apr 30, 2023 | 12 | 0 | - |
| Apr 30, 2022 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nuwellis | 59 |
| Sonoma Pharmaceuticals | 10 |
| Channel Therapeutics | 8 |
| TNF Pharmaceuticals | 6 |
| 180 Life Sciences | 4 |
| Creative Medical Technology Holdings | 4 |
| Silo Pharma | 3 |
| GT Biopharma | 2 |
HSCS News
- 5 days ago - HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - GlobeNewsWire
- 2 months ago - HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 3 months ago - HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 3 months ago - HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission - GlobeNewsWire
- 5 months ago - HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results - GlobeNewsWire
- 5 months ago - Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - GlobeNewsWire
- 5 months ago - HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - GlobeNewsWire